PharmaCyte Biotech, Inc. - Common Stock (PMCB)
Seasonality Analysis
PharmaCyte Biotech, Inc. - Common Stock Annual Seasonality Statistics
PharmaCyte Biotech, Inc. - Common Stock Monthly Seasonality Performance
| Month | Avg Return | Win Rate | Strength |
|---|---|---|---|
| January | 12.31% | Moderate | |
| February BEST | 15.92% | Weak | |
| March | -4.33% | Very Weak | |
| April | -2.18% | Weak | |
| May | -3.71% | Very Weak | |
| June | -3.44% | Very Weak | |
| July | -1.02% | Weak | |
| August WORST | -18.56% | Very Weak | |
| September | 1.07% | Weak | |
| October | -2.90% | Very Weak | |
| November | -1.71% | Very Weak | |
| December | 2.31% | Weak |
PharmaCyte Biotech, Inc. - Common Stock 2026 vs Historical Pattern
PharmaCyte Biotech, Inc. - Common Stock Interactive Seasonality Chart
PharmaCyte Biotech, Inc. - Common Stock Pattern Scanner
PharmaCyte Biotech, Inc. - Common Stock Seasonal Historical Performance
About PharmaCyte Biotech, Inc. - Common Stock (PMCB) Seasonality
PharmaCyte Biotech, Inc. - Common Stock (PMCB) has been analyzed using 14 years of historical data to identify seasonal patterns. Classified under Stocks, PharmaCyte Biotech, Inc. - Common Stock shows distinct seasonal tendencies based on historical data.
The strongest month for PharmaCyte Biotech, Inc. - Common Stock is historically February, with an average return of 15.92% and a win rate of 43%. Conversely, August tends to be the weakest month, averaging -18.56% return.
Looking at the full calendar year, PharmaCyte Biotech, Inc. - Common Stock has an average annual return of -6.25% with an overall monthly win rate of 36.7%. Out of 12 months, 4 typically show positive average returns.
The seasonal pattern for PharmaCyte Biotech, Inc. - Common Stock has a consistency score of 51 (Fair), based on 14 years of data. Higher consistency means the seasonal pattern has been more reliable across different market conditions.
PharmaCyte Biotech, Inc. - Common Stock Seasonality FAQ
What is the best month to buy PharmaCyte Biotech, Inc. - Common Stock (PMCB)?
Historically, February has been the best month for PharmaCyte Biotech, Inc. - Common Stock, with an average return of 15.92% and a win rate of 43%. However, past performance does not guarantee future results.
What is the worst month for PharmaCyte Biotech, Inc. - Common Stock (PMCB)?
Based on historical data, August has been the weakest month for PharmaCyte Biotech, Inc. - Common Stock, with an average return of -18.56%. This is a historical observation and does not guarantee future results.
How reliable is PMCB seasonality data?
The seasonality analysis for PharmaCyte Biotech, Inc. - Common Stock is based on 14 years of historical price data. While seasonal patterns can provide useful insights, they should be combined with other forms of analysis. Past patterns do not guarantee future performance.
How can I use PharmaCyte Biotech, Inc. - Common Stock seasonality in my trading?
Use PharmaCyte Biotech, Inc. - Common Stock (PMCB) seasonality as one factor in your analysis. Identify historically strong and weak months, combine with other research methods. SeasOptima provides premium tools including interactive charts, pattern scanning, and historical performance data for deeper analysis.